Search:
This item requires a subscription.
The case for specialist surgery LCIP, Volume 5, Number 3.
The five-year survival rate for lung cancer (LC) in England for patients diagnosed in 2000–2002 was estimated to be 8.4%. While this has slowly improved over the last ten years, it is below the average for the rest of Europe (10.9%), and the USA (15.7%) for the same period. There are also wide variations in survival across the UK. Since, with current therapeutic options, surgical resection is by far the treatment most likely to result in survival to five years and beyond, it is vital that we examine possible shortcomings and variations in surgical practice.
To view this item, select one of the options below:
Purchase access
Sign in
email address
Password
Important
All the articles are in PDF format.
To view the articles you will need Adobe Acrobat Reader.
To download a copy, free of charge, please click here.